Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 21 for “"PLGA nanoparticles"”.
-
Development of versatile drug delivery strategies using PLGA nanoparticles
… to improve efficacy. Development of polymeric nanoparticles (NP) with slow drug-release kinetics coated with targeting ligands enables cell-specific sustained drug delivery, whilst minimising off-target side effects. In this thesis, a range of novel poly(lactic-co- glycolic acid) (PLGA) NP …
-
Consistent Fabrication of Ultrasmall PLGA Nanoparticles and their Potential Biomedical Applications
… the last few decades. Specifically, ultrasmall nanoparticles, ranging in size from 5 to 50 nm, are highly sought after for their physical and chemical properties and their ability to be easily transmitted though the bloodstream. By adjusting the material properties, size, surface potential, …
-
INVESTIGATION OF LIGAND SIZE ON TARGETED PLGA NANOPARTICLES FOR HER2 BREAST CANCER: TRASTUZUMAB AND ITS ScFv ANTI-HER2 ANTIBODY
… breast cancer. Poly (D, L-lactide-co-glycolide) (PLGA) polymer, which is approved by FDA, was used to form nanoparticles (NPs) encapsulating docetaxel (DOC) as chemotherapy. HER2 antibody moieties, either whole IgG (TrAb) or single chain fragment variable (ScFv), were decorated on the PLGA NPs …
-
Preparation and characterization of poly lactic-co-glycolic nanoparticles encapsulated with gentamicin for drug delivery applications
… have been dramatically improved. The ues of nanoparticles encapsulated with antibiotics to deliver drugs has been shown to be a potentially effective approach to control bacterial infections at a wound position. Recently, biodegradable and biocompatible polymers have drawn lots of attention …
-
Multifunctional Nanoparticles for Cancer Therapy
… present study was to develop and characterize nanoparticles containing two anticancer agents having different mechanisms of action that would target both differentiated as well as cancer stem cells. The two hydrophobic antitumor agents (cyclopamine and paclitaxel) were entrapped in glyceryl …
-
Development and characterization of advanced nitric oxide-delivering polymeric systems against cardiovascular complications
… incorporated with poly(lactic-co-glycolic acid) (PLGA) nanoparticles containing DETA NONOate were formulated for the prevention of valve complications. Similarly, S-nitrosoglutathione incorporated polycaprolactone (PCL) matrix system was developed for combating in-stent restenosis. PLLA matrices …
-
Development of SiRNA Incorporated Surface Modified Polymeric Nanoparticle for the Potential Treatment of Global Cerebral Ischemia
… issue and suppress BRD4, this study developed PLGA nanoparticles coated with Polysorbate-80 (PS-80) and Polyethylene glycol (PEG) to incorporate siRNA and effectively deliver across the BBB. The study engineered siRNA-incorporated PLGA nanoparticles with PS-80 and PEG coating via a modified …
-
Biophysical characterization of hydrogel-core, lipid-shell nanoparticles (nanolipogels) for HIV chemoprophylaxis
Nanoparticles are emerging as versatile vehicles for drug delivery, providing targeting, protection, and controlled-release capabilities to encapsulated cargo. Polymeric nanoparticles made from poly(lactide-co-glycolide) (PLGA) are biodegradable, exhibit tunable drug release, and have encapsulated …
-
Targeting macrophages GLP-1 receptor pathways as emerging therapies to ameliorate cardiac remodelling associated with diabetes
… we employed poly (lactic-co-glycolic acid) (PLGA) nanoparticles for preferential targeting of liraglutide and exendin-4 to inflammatory cells. Whilst liraglutide-PLGA nanoparticles displayed equivalent GLP-1R binding and activation to native liraglutide in U2OS cells and CHL cells, …
-
Development and Characterization of Controlled Drug Delivery Using Nanoparticles
… biodegradable Poly (DL-lactideco- glycolide) (PLGA) nanoparticles by simple nanoprecipitation method. The small size of these particles (<200nm) could be beneficial to realize passive tumor-targeted drug delivery through enhanced permeability and retention (EPR) effects. These drug-containing …
-
Polyelectrolyte multilayers for tunable release of antibiotics and other therapeutics
… incorporation of poly(lactic-co-glycolic acid) (PLGA) nanoparticles encapsulating gentamicin, [7] evaluation of film sterilizability via FDA-approved methods, and [8] design and characterization of a multi-drug coating for orthopedic implants for dual antimicrobial and tissue regenerative actions.
-
Synthesis and Characterization of Multi-Functional Nanoparticles for Therapeutic and Biosensing Applications
… of poly(DL-lactic acid-co-glycolic acid) (PLGA) or poly(ethylene glycol)-PLGA and stabilized by polyvinyl alcohol (PVA) or Pluronic F-68 for the encapsulation of an insulin derivative, a model therapeutic enzyme, and anticancer drugs. The protein hormone release from biodegradable …
-
Nanoparticle-Based Drug Delivery and the Impacts on Cancer Cell Biophysical Markers
… delivery using Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) loaded with SphKIs versus conventional delivery. Cells treated with SphKIs showed significantly higher impedance magnitudes at all four frequencies. The bioelectrical parameters extracted using a model also revealed that …
-
Combination of STING and TLR 7/8 agonists as vaccine adjuvants for cancer immunotherapy
… agonists, individually or in combination. Also, PLGA nanoparticles were formulated and characterized in vitro. We observed that the combined treatment showed enhanced DC activation and M2 repolarization compared to the individual agonists. However, we also observed an increased induction of …
-
Novel Transporter Targeted Lipid Ester Prodrugs of Cidofovir and Sustained Release Formulations for Cytomegalovirus Infection
… virus strains. Furthermore, prodrug loaded PLGA nanoparticle formulations were prepared and characterized. Overall, improvement in physicochemical properties, lipophilicity, interaction with SMVT transporter, higher tissue-buffer partition coefficient and rapid conversion into parent …
-
Antioxidant Nanoparticles as Delivery Systems
… the study was to develop antioxidant polymeric nanoparticles as a new delivery system for food and pharmaceutical applications. Natural antioxidants like alpha-tocopherol, vitamin C, and carnosine, are responsible to protect biological systems against free radicals attack. The conjugation of …
-
Role of Soluble [alpha]-Klotho in the Alleviation of Acute Lung Injury
… incorporated into poly-lactic-co-glycolic-acid (PLGA) nanoparticles (NPs), a vehicle chosen for its desired properties suitable for inhalational delivery. Klotho-containing PLGA NPs were characterized for inhalational delivery and screened in A549 cells exposed to cigarette smoke. WT or …
-
Engineering Materials for Non-Compressible Torso Hemorrhage and Internal Bleeding
… size on their interactions with platelets. Small nanoparticles were observed to result in an increased percentage of specifically-bound single platelets under flow and intermediate nanoparticles were observed to result in the greatest degree of platelet recruitment to a platelet-collagen surface. …
-
Tools for decoding the structure-function relationships of biopolymers in nanotechnology and glycobiology
… dexamethasone from poly lactic-co-glycolic acid (PLGA) nanoparticles is precisely predicted. The Voxel platform emerges as a powerful and versatile tool for deducing the dynamics in interplay of polymer, drug, and water molecules, thus permitting the rational design of optimal nanotechnology …
-
Topical Nanoparticulate Formulation of Drugs for Ocular Keratitis
… this project is to develop drug-loaded polymeric nanoparticles suspended in a biocompatible gel for topical delivery of therapeutic agents commonly employed in the treatment of ocular viral/bacterial keratitis. PART 1: Poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles (NP) of dipeptide …
Page 1 of 2